247 HYPOALBUMINEMIA IS A SURROGATE BIOMARKER OF POOR PROGNOSIS IN MYELODYSPLASTIC SYNDROME EVEN WHEN ADJUSTED WITH COMORBIDITIES

O. Sevindik, Z. Guc, S. Kahraman, S. Medeni, A. Katgi, C. Acar, I. Alacacioglu, O. Piskin, H. Ozsan, F. Demirkan, B. Undar, M. Ozcan

Leukemia Research(2015)

引用 8|浏览37
暂无评分
关键词
myelodysplastic syndrome,hypoalbuminemia,poor prognosis,surrogate biomarker
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要